Report
Olga Smolentseva

BIONTECH | BUY Top Picks | USD120

BIONTECH | BUY Top Picks | USD120
With additional confidence in Comirnaty, agreement with the EC could be expanded soon
Early data suggest Comirnaty’s efficacy against daunting mutation
Anticipating EC supply agreement to be expanded up to 600m doses
Underlying
Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Olga Smolentseva

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch